These findings shed light on the mechanisms underlying muscle atrophy caused by obesity and T2DM and suggest that NGF could be a potential therapeutic agent for preventing muscle atrophy in these conditions. The gene discussed is NGF; the disease is type 2 diabetes mellitus.